Chattem Banks On “Best New Product Lineup” To Fuel 2006 Sales

Icy Hot and Selsun line extensions will drive 2006 top line growth in the 20-25% range and earnings growth to 10-15%, Chattem projects

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet